Alto Neuroscience (ANRO) vs Seaport Therapeutics (SPTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Seaport Therapeutics is the larger company by market cap ($964.9 million vs $942.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANRO | SPTX |
|---|---|---|
| Share price | $24.03 | $18.03 |
| Market cap | $942.79M | $964.89M |
| 1-day change | +2.15% | +0.53% |
| YTD return | +32.13% | — |
| 1-year return | +295.96% | — |
| EPS (TTM) | $-2.31 | $-5.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.48 | $28.38 |
| 52-week low | $5.23 | $14.85 |
| Distance from 52-week high | -35.90% | -36.49% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +59.75% | +112.43% |
| Average volume | 540.09K | 182.18K |
| Shares outstanding | 39.24M | 53.53M |
| Employees | 68 | 58 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Alto Neuroscience
ANRO stock →Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 68 employees
About Seaport Therapeutics
SPTX stock →Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.
Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees
ANRO vs SPTX FAQ
Which is bigger, Alto Neuroscience or Seaport Therapeutics?
Seaport Therapeutics (SPTX) is larger, with a market capitalization of $964.89M compared with $942.79M for Alto Neuroscience (ANRO).
Are Alto Neuroscience and Seaport Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.